Caleb Bliss

Caleb Bliss is an accomplished biostatistician currently serving as Executive Director of Biostatistics at Dyne Therapeutics since September 2025. Prior to this role, Caleb held various positions at Apellis Pharmaceuticals from September 2020 to September 2025, including Senior Director and Director of Biostatistics. From October 2015 to September 2020, Caleb worked at Shire as Associate Director and Senior Biostatistician II. Additional experience includes a tenure as Senior Biostatistician at Cubist Pharmaceuticals from November 2014 to August 2015, and as Senior Biostatistician and Biostatistician at PROMETRIKA, LLC from September 2010 to November 2014. Early career positions include Research Data Analyst and Statistical Data Assistant at Boston University Data Coordinating Center, as well as a Data Manager at Massachusetts General Hospital. Caleb earned a Doctor of Philosophy in Biostatistics and a Master of Arts in Biostatistics from Boston University, following a Bachelor of Arts in Mathematics from Williams College.